GB2307858B - Medical treatment - Google Patents

Medical treatment

Info

Publication number
GB2307858B
GB2307858B GB9625316A GB9625316A GB2307858B GB 2307858 B GB2307858 B GB 2307858B GB 9625316 A GB9625316 A GB 9625316A GB 9625316 A GB9625316 A GB 9625316A GB 2307858 B GB2307858 B GB 2307858B
Authority
GB
United Kingdom
Prior art keywords
medical treatment
medical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9625316A
Other versions
GB9625316D0 (en
GB2307858A (en
Inventor
Keith Frederick Rhodes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of GB9625316D0 publication Critical patent/GB9625316D0/en
Publication of GB2307858A publication Critical patent/GB2307858A/en
Application granted granted Critical
Publication of GB2307858B publication Critical patent/GB2307858B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9625316A 1995-12-09 1996-12-05 Medical treatment Expired - Fee Related GB2307858B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9525239.1A GB9525239D0 (en) 1995-12-09 1995-12-09 Medical treatment

Publications (3)

Publication Number Publication Date
GB9625316D0 GB9625316D0 (en) 1997-01-22
GB2307858A GB2307858A (en) 1997-06-11
GB2307858B true GB2307858B (en) 1999-07-28

Family

ID=10785215

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9525239.1A Pending GB9525239D0 (en) 1995-12-09 1995-12-09 Medical treatment
GB9625316A Expired - Fee Related GB2307858B (en) 1995-12-09 1996-12-05 Medical treatment

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9525239.1A Pending GB9525239D0 (en) 1995-12-09 1995-12-09 Medical treatment

Country Status (1)

Country Link
GB (2) GB9525239D0 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5527152A (en) * 1978-08-18 1980-02-27 Mitsui Toatsu Chem Inc Immunizator containing 1-piperazinecarboxyamide derivative as effective ingredient
GB2230781A (en) * 1989-04-22 1990-10-31 Wyeth John & Brother Ltd Piperazine derivatives as 5-ht(1a) antagonists
GB2230780A (en) * 1989-04-22 1990-10-31 American Home Prod Tertiary alkyl functionalised piperazine derivatives
GB2248836A (en) * 1990-10-19 1992-04-22 Wyeth John & Brother Ltd Piperazine derivatives
GB2255337A (en) * 1991-05-02 1992-11-04 Wyeth John & Brother Ltd Piperazine derivatives
GB2272155A (en) * 1992-11-05 1994-05-11 Wyeth John & Brother Ltd Piperazine derivatives for treatment of cognitive disorders
WO1995031988A1 (en) * 1994-05-25 1995-11-30 Smithkline Beecham P.L.C. COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5527152A (en) * 1978-08-18 1980-02-27 Mitsui Toatsu Chem Inc Immunizator containing 1-piperazinecarboxyamide derivative as effective ingredient
GB2230781A (en) * 1989-04-22 1990-10-31 Wyeth John & Brother Ltd Piperazine derivatives as 5-ht(1a) antagonists
GB2230780A (en) * 1989-04-22 1990-10-31 American Home Prod Tertiary alkyl functionalised piperazine derivatives
GB2248836A (en) * 1990-10-19 1992-04-22 Wyeth John & Brother Ltd Piperazine derivatives
GB2255337A (en) * 1991-05-02 1992-11-04 Wyeth John & Brother Ltd Piperazine derivatives
GB2272155A (en) * 1992-11-05 1994-05-11 Wyeth John & Brother Ltd Piperazine derivatives for treatment of cognitive disorders
WO1995031988A1 (en) * 1994-05-25 1995-11-30 Smithkline Beecham P.L.C. COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chemical abstracts Acc. No. 93:210249 & JP550027152 (MITSUI TOATSU CHEM.) *

Also Published As

Publication number Publication date
GB9625316D0 (en) 1997-01-22
GB2307858A (en) 1997-06-11
GB9525239D0 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
GB2298440B (en) Well treatment
ZA978450B (en) Medical treatment
AU6913796A (en) Patient treatment apparatus
HUP9901089A3 (en) Medical splint
GB9519033D0 (en) Treatment
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
HUP9901448A3 (en) Novel medical use
GB9217124D0 (en) Medical treatment
GB9408084D0 (en) Medical treatment
GB9526264D0 (en) Medical treatment
GB2307858B (en) Medical treatment
GB9608631D0 (en) Medical treatment
GB9403306D0 (en) Medical treatment
GB9425773D0 (en) Medical treatment
GB9421398D0 (en) Medical treatment
GB9424728D0 (en) Medical treatment
GB9425164D0 (en) Medical treatment
GB9626265D0 (en) Medical treatment
GB9626859D0 (en) Medical treatment
GB9618375D0 (en) Medical treatment
GB9602728D0 (en) Medical treatment
GB9621327D0 (en) Medical treatment
GB9612330D0 (en) Medical treatment
GB9321793D0 (en) Medical treatment

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20011205